Literature DB >> 11079803

Friulimicins: novel lipopeptide antibiotics with peptidoglycan synthesis inhibiting activity from Actinoplanes friuliensis sp. nov. I. Taxonomic studies of the producing microorganism and fermentation.

W Aretz1, J Meiwes, G Seibert, G Vobis, J Wink.   

Abstract

A strain that produces new lipopeptide antibiotics is a new species of the genus Actinoplanes for which we propose the name Actinoplanes friuliensis (type strain: HAG 010964). The strain is an actinoplanete actinomycete having cell wall II composition and forming sporangia. Comparisons with Actinoplanes spp. which have similarities with our isolate, including fatty acid analysis, showed that the isolate belongs to a new species. Taxonomic studies and fermentation are presented.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11079803     DOI： 10.7164/antibiotics.53.807

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


  10 in total

1.  Sequencing and analysis of the biosynthetic gene cluster of the lipopeptide antibiotic Friulimicin in Actinoplanes friuliensis.

Authors:  C Müller; S Nolden; P Gebhardt; E Heinzelmann; C Lange; O Puk; K Welzel; W Wohlleben; D Schwartz
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

2.  Crystallomycin revisited after 60 years: aspartocins B and C.

Authors:  Anton P Tyurin; Vera A Alferova; Alexander S Paramonov; Maxim V Shuvalov; Irina A Malanicheva; Natalia E Grammatikova; Pavel N Solyev; Shaowei Liu; Chenghang Sun; Igor A Prokhorenko; Tatyana A Efimenko; Larisa P Terekhova; Olga V Efremenkova; Zakhar O Shenkarev; Vladimir A Korshun
Journal:  Medchemcomm       Date:  2018-02-27       Impact factor: 3.597

Review 3.  Targeting the Achilles' Heel of Bacteria: Different Mechanisms To Break Down the Peptidoglycan Cell Wall during Bacterial Warfare.

Authors:  Stephanie Sibinelli-Sousa; Julia Takuno Hespanhol; Ethel Bayer-Santos
Journal:  J Bacteriol       Date:  2021-03-08       Impact factor: 3.490

Review 4.  The calcium-dependent lipopeptide antibiotics: structure, mechanism, & medicinal chemistry.

Authors:  Thomas M Wood; Nathaniel I Martin
Journal:  Medchemcomm       Date:  2019-03-21       Impact factor: 3.597

5.  Molecular cloning and identification of the laspartomycin biosynthetic gene cluster from Streptomyces viridochromogenes.

Authors:  Yang Wang; Ying Chen; Qirong Shen; Xihou Yin
Journal:  Gene       Date:  2011-05-27       Impact factor: 3.688

6.  Surfactin Shows Relatively Low Antimicrobial Activity against Bacillus subtilis and Other Bacterial Model Organisms in the Absence of Synergistic Metabolites.

Authors:  Lars Lilge; Nadine Ersig; Philipp Hubel; Moritz Aschern; Evelina Pillai; Peter Klausmann; Jens Pfannstiel; Marius Henkel; Kambiz Morabbi Heravi; Rudolf Hausmann
Journal:  Microorganisms       Date:  2022-04-05

7.  A glutamate mutase is involved in the biosynthesis of the lipopeptide antibiotic friulimicin in Actinoplanes friuliensis.

Authors:  E Heinzelmann; S Berger; O Puk; B Reichenstein; W Wohlleben; D Schwartz
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

8.  Daptomycin versus Friulimicin B: in-depth profiling of Bacillus subtilis cell envelope stress responses.

Authors:  Tina Wecke; Daniela Zühlke; Ulrike Mäder; Sina Jordan; Birgit Voigt; Stefan Pelzer; Harald Labischinski; Georg Homuth; Michael Hecker; Thorsten Mascher
Journal:  Antimicrob Agents Chemother       Date:  2009-01-21       Impact factor: 5.191

9.  The expression of the acarbose biosynthesis gene cluster in Actinoplanes sp. SE50/110 is dependent on the growth phase.

Authors:  Julian Droste; Vera Ortseifen; Lena Schaffert; Marcus Persicke; Susanne Schneiker-Bekel; Alfred Pühler; Jörn Kalinowski
Journal:  BMC Genomics       Date:  2020-11-23       Impact factor: 3.969

10.  A maltose-regulated large genomic region is activated by the transcriptional regulator MalT in Actinoplanes sp. SE50/110.

Authors:  Julian Droste; Martin Kulisch; Timo Wolf; Lena Schaffert; Susanne Schneiker-Bekel; Alfred Pühler; Jörn Kalinowski
Journal:  Appl Microbiol Biotechnol       Date:  2020-09-28       Impact factor: 4.813
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.